Evidence map›Paper›PMID 26451481›Full record

ReviewCell2015

Pausing on Polyribosomes: Make Way for Elongation in Translational Control.

Joel D Richter, Jeff Coller

Abstract readReview
In one paragraph

Review in Cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genome-wide profiling of RNA 2'-bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Perturbation of METTL1-mediated tRNA NNature communications · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Autism- and epilepsy-associatedProceedings of the National Academy of Sciences of the United States of America · 2023
    Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joel D RichterProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: joel.richter@umassmed.edu.
Jeff CollerCenter for RNA Molecular Biology, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address: jmc71@case.edu.

Funding

Strategies to rescue PI3K dysregulation in Fragile X SyndromeU54HD082013 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RICHTER, JOEL D · 2014 to 2019
$10.2M
POLYADENYLATION AND TRANSLATIONAL CONTROLR01GM046779 · NIGMS · WORCESTER FOUNDATION FOR BIOMEDICAL RES · PI RICHTER, JOEL D · 1992 to 2022
$7.7M
Understanding the interconnection between mRNA turnover and mRNA translationR01GM080465 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI COLLER, JEFFERY · 2007 to 2016
$2.7M
Mechanisms of Translation in the CNSR01NS079415 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RICHTER, JOEL D · 2013 to 2017
$1.9M
NICHD NIH HHS U54 HD082013NIGMS NIH HHS R01 GM046779NIGMS NIH HHS R01 GM080465NIGMS NIH HHS R01 GM46779NINDS NIH HHS R01 NS079415PHS HHS U54 082013
6 · The paper itself

Abstract

Among the three phases of mRNA translation-initiation, elongation, and termination-initiation has traditionally been considered to be rate limiting and thus the focus of regulation. Emerging evidence, however, demonstrates that control of ribosome translocation (polypeptide elongation) can also be regulatory and indeed exerts a profound influence on development, neurologic disease, and cell stress. The correspondence of mRNA codon usage and the relative abundance of their cognate tRNAs is equally important for mediating the rate of polypeptide elongation. Here, we discuss recent results showing that ribosome pausing is a widely used mechanism for controlling translation and, as a result, biological transitions in health and disease.

Indexed as

Gene Expression RegulationPeptide Chain Elongation, TranslationalAnimalsCodonDiseaseHumansPeptide Chain Initiation, TranslationalPolyribosomesRNA, MessengerRNA, TransferCodonRNA, MessengerRNA, Transfer

Identifiers

PMID26451481
PMCPMC4600128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.